Viewing Study NCT01392703


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-05-22 @ 1:45 PM
Study NCT ID: NCT01392703
Status: COMPLETED
Last Update Posted: 2013-02-11
First Post: 2011-07-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pharmacokinetic Study in Healthy Participants View
Keywords: